Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415103430> ?p ?o ?g. }
- W2415103430 abstract "Abstract Necroptosis, or programmed necrosis, contributes to the formation of necrotic cores in atherosclerotic plaque in animal models. However, whether inhibition of necroptosis ameliorates atherosclerosis is largely unknown. In this study, we demonstrated that necroptosis occurred in clinical atherosclerotic samples, suggesting that it may also play an important role in human atherosclerosis. We established an in vitro necroptotic model in which necroptosis was induced in THP-1-derived foam cells by serum deprivation. With this model, we demonstrated that 5-aminolevulinic acid-mediated sonodynamic therapy (ALA-SDT) inhibited necroptosis while promoting apoptosis. ALA-SDT activated the caspase-3 and caspase-8 pathways in foam cells, which is responsible for the switch from necroptosis to apoptosis. The inhibition of either caspase-8 or caspase-3 abolished the anti-necroptotic effect of ALA-SDT. In addition, we found that caspase-3 activation peaked 4 hours after ALA-SDT treatment, 2 hours earlier than maximal caspase-8activation. Taken together, our data indicate that ALA-SDT mediates the switch from necroptosis to apoptosis by activating the caspase-3 and caspase-8 pathways and may improve the prognosis of atherosclerosis." @default.
- W2415103430 created "2016-06-24" @default.
- W2415103430 creator A5001428421 @default.
- W2415103430 creator A5014528965 @default.
- W2415103430 creator A5017894990 @default.
- W2415103430 creator A5018397526 @default.
- W2415103430 creator A5018882443 @default.
- W2415103430 creator A5021606010 @default.
- W2415103430 creator A5023564133 @default.
- W2415103430 creator A5037816329 @default.
- W2415103430 creator A5039649740 @default.
- W2415103430 creator A5044396095 @default.
- W2415103430 creator A5046597133 @default.
- W2415103430 creator A5048882337 @default.
- W2415103430 creator A5064642018 @default.
- W2415103430 creator A5065608852 @default.
- W2415103430 creator A5068365109 @default.
- W2415103430 creator A5074637852 @default.
- W2415103430 creator A5075189232 @default.
- W2415103430 creator A5077869711 @default.
- W2415103430 creator A5081316721 @default.
- W2415103430 date "2016-02-25" @default.
- W2415103430 modified "2023-10-05" @default.
- W2415103430 title "5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells" @default.
- W2415103430 cites W1855690543 @default.
- W2415103430 cites W1964064254 @default.
- W2415103430 cites W1964182229 @default.
- W2415103430 cites W1965278769 @default.
- W2415103430 cites W1976881265 @default.
- W2415103430 cites W1979032223 @default.
- W2415103430 cites W1983078635 @default.
- W2415103430 cites W1984487910 @default.
- W2415103430 cites W1985231277 @default.
- W2415103430 cites W1985749510 @default.
- W2415103430 cites W1994301968 @default.
- W2415103430 cites W1995391763 @default.
- W2415103430 cites W1998983498 @default.
- W2415103430 cites W2002102464 @default.
- W2415103430 cites W2005138952 @default.
- W2415103430 cites W2011698659 @default.
- W2415103430 cites W2013933536 @default.
- W2415103430 cites W2015046207 @default.
- W2415103430 cites W2016883314 @default.
- W2415103430 cites W2021655408 @default.
- W2415103430 cites W2027698698 @default.
- W2415103430 cites W2030702538 @default.
- W2415103430 cites W2038096193 @default.
- W2415103430 cites W2039267077 @default.
- W2415103430 cites W2042577315 @default.
- W2415103430 cites W2063251795 @default.
- W2415103430 cites W2069250210 @default.
- W2415103430 cites W2071978180 @default.
- W2415103430 cites W2077214694 @default.
- W2415103430 cites W2083565374 @default.
- W2415103430 cites W2088032380 @default.
- W2415103430 cites W2090263751 @default.
- W2415103430 cites W2091263717 @default.
- W2415103430 cites W2091802222 @default.
- W2415103430 cites W2099956255 @default.
- W2415103430 cites W2104209640 @default.
- W2415103430 cites W2110796758 @default.
- W2415103430 cites W2113494971 @default.
- W2415103430 cites W2120626244 @default.
- W2415103430 cites W2128003689 @default.
- W2415103430 cites W2131763938 @default.
- W2415103430 cites W2132161879 @default.
- W2415103430 cites W2139552156 @default.
- W2415103430 cites W2142552972 @default.
- W2415103430 cites W2164977248 @default.
- W2415103430 cites W2166635466 @default.
- W2415103430 cites W4237720194 @default.
- W2415103430 cites W4254283855 @default.
- W2415103430 doi "https://doi.org/10.1038/srep21992" @default.
- W2415103430 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4766406" @default.
- W2415103430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26911899" @default.
- W2415103430 hasPublicationYear "2016" @default.
- W2415103430 type Work @default.
- W2415103430 sameAs 2415103430 @default.
- W2415103430 citedByCount "43" @default.
- W2415103430 countsByYear W24151034302016 @default.
- W2415103430 countsByYear W24151034302017 @default.
- W2415103430 countsByYear W24151034302018 @default.
- W2415103430 countsByYear W24151034302019 @default.
- W2415103430 countsByYear W24151034302020 @default.
- W2415103430 countsByYear W24151034302021 @default.
- W2415103430 countsByYear W24151034302022 @default.
- W2415103430 countsByYear W24151034302023 @default.
- W2415103430 crossrefType "journal-article" @default.
- W2415103430 hasAuthorship W2415103430A5001428421 @default.
- W2415103430 hasAuthorship W2415103430A5014528965 @default.
- W2415103430 hasAuthorship W2415103430A5017894990 @default.
- W2415103430 hasAuthorship W2415103430A5018397526 @default.
- W2415103430 hasAuthorship W2415103430A5018882443 @default.
- W2415103430 hasAuthorship W2415103430A5021606010 @default.
- W2415103430 hasAuthorship W2415103430A5023564133 @default.
- W2415103430 hasAuthorship W2415103430A5037816329 @default.
- W2415103430 hasAuthorship W2415103430A5039649740 @default.
- W2415103430 hasAuthorship W2415103430A5044396095 @default.
- W2415103430 hasAuthorship W2415103430A5046597133 @default.
- W2415103430 hasAuthorship W2415103430A5048882337 @default.